Raymond James Financial Services Advisors’s AbbVie ABBV Stock Holding History

Raymond James Financial Services Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-36,000	Closed	-$121K	–	3255
2022 Q1	$121K	Sell	36,000 -100	-0.3%	-$14.5K	﹤0.01%	3080
2021 Q4	$49K	Buy	+36,100	New	+$4.26M	﹤0.01%	3191
2021 Q2	–	Sell	-38,000	Closed	-$8K	–	3299
2021 Q1	$8K	Sell	38,000 -4,300	-10%	-$460K	﹤0.01%	3157
2020 Q4	$56K	Buy	+42,300	New	+$4.06M	﹤0.01%	2906
2019 Q2	–	Sell	-24,000	Closed	-$3K	–	2841
2019 Q1	$3K	Buy	+24,000	New	+$1.96M	﹤0.01%	2789

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Raymond James Financial Services Advisors's ABBV Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its AbbVie (ABBV) stake by 2.9% in Q3 2024, buying an estimated $6M and bringing the position to 1,124,281 shares worth $222M. The position accounts for 0.3% of the portfolio, ranked #69.

Raymond James Financial Services Advisors first reported a position in ABBV in Q2 2013 and has held it in 46 quarters since. 3,499 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

Raymond James Financial Services Advisors held 1,124,281 shares of AbbVie worth $222M as of Q3 2024.
Raymond James Financial Services Advisors bought 32,129 AbbVie shares in Q3 2024, an estimated $6M.
AbbVie made up 0.3% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #69 holding.
Raymond James Financial Services Advisors first reported a position in AbbVie in Q2 2013 and has held it in 46 quarters since.
3,499 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.